Home / Health / Ozempic for Paws? Pet Obesity Jab Trial Begins

Ozempic for Paws? Pet Obesity Jab Trial Begins

Summary

  • US pilot study tests GLP-1 drugs, similar to Ozempic, on cats.
  • Injectable implant aims to manage overweight cats and suppress hunger.
  • Potential cost under $100 monthly could save owners money.
Ozempic for Paws? Pet Obesity Jab Trial Begins

Pet obesity is a significant issue in countries like the US and UK, with estimates suggesting a majority of pets are overweight. Owners' perceptions of pet happiness tied to appetite contribute to this problem.

In response, a pilot study in the United States is now exploring GLP-1 drugs, a class including Ozempic and Wegovy, for use in cats. This research focuses on an injectable implant designed to manage feline weight by mimicking hormones that slow digestion and reduce hunger.

This innovative treatment, dubbed MEOW-1, could potentially cost owners less than $100 per month. This offers a more affordable alternative to current practices where veterinarians prescribe human-grade medications off-label at higher prices.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, a pilot study is currently testing GLP-1 drugs, similar to Ozempic, on cats for weight management.
The company behind the trial hopes to keep the cost under $100 per month for the new injectable treatment.
MEOW-1 stands for 'ManagEment of Over Weight cats,' a pilot study testing a six-month injectable implant for feline weight loss.

Read more news on